| Literature DB >> 30183485 |
Manish Ramesh1, Merhunisa Karagic1.
Abstract
Allergen immunotherapy is a rapidly evolving field. Although subcutaneous immunotherapy has been practiced for over a hundred years, improved understanding of the underlying immunological mechanisms has led to the development of new, efficacious and better tolerated allergen-derivatives, adjuvants and encapsulated allergens. Diverse routes of allergen immunotherapy - oral, sublingual, epicutanoeus and intralymphatic - are enabling immunotherapy for anaphylactic food allergies and pollen-food allergy syndrome, while improving the tolerability and effectiveness of aeroallergen immunotherapy. The addition of Anti-IgE therapy decreases adverse effects of subcutaneous and oral immunotherapy.Entities:
Keywords: Allergen Immunotherapy; Anti-IgE; Epicutaneous Immunotherapy; Oral Immunotherapy; Subcutaneous Immunotherapy; Sublingual Immunotherapy; adjuvants
Year: 2018 PMID: 30183485 PMCID: PMC6343630 DOI: 10.1080/21645515.2018.1502126
Source DB: PubMed Journal: Hum Vaccin Immunother ISSN: 2164-5515 Impact factor: 3.452